Compile Data Set for Download or QSAR

Found 135 hits Enz. Inhib. hit(s) with all data for entry = 2071   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354311 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1 Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354293 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354310 (3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354332 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354293 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354311 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1 Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354310 (3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354324 (1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...) Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354324 (1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...) Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354304 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354309 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354304 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354331 (3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC(F)(F)F)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C45H49F3N9O6P/c1-44(2,3)38-27-39(57(55-38)32-10-8-9-29(23-32)28-64(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-31-24-30(25-33(26-31)63-45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354329 (1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354330 (3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(F)(F)F)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C45H49F3N9O5P/c1-44(2,3)38-27-39(57(55-38)33-10-8-9-29(23-33)28-63(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-32-25-30(24-31(26-32)45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354323 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(OCCN2CCOCC2)c1 Show InChI InChI=1S/C44H50N7O6P/c1-30(2)40-28-43(51(49-40)33-10-8-9-31(23-33)29-58(4,5)53)48-44(52)47-39-13-14-41(38-12-7-6-11-37(38)39)57-34-15-16-45-42(27-34)46-32-24-35(54-3)26-36(25-32)56-22-19-50-17-20-55-21-18-50/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,45,46)(H2,47,48,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354273 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354332 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354308 (1-(3-(tert-Butyl)-1-(3-((diethylphosphoryl)methyl)...) Show SMILES CCP(=O)(CC)Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C41H44N9O3P/c1-7-54(52,8-2)25-27-12-11-13-30(21-27)50-36(23-35(49-50)41(4,5)6)46-40(51)45-33-16-17-34(32-15-10-9-14-31(32)33)53-37-18-19-42-39(47-37)44-29-20-26(3)38-28(22-29)24-43-48-38/h9-24H,7-8,25H2,1-6H3,(H,43,48)(H,42,44,47)(H2,45,46,51)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354329 (1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354308 (1-(3-(tert-Butyl)-1-(3-((diethylphosphoryl)methyl)...) Show SMILES CCP(=O)(CC)Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C41H44N9O3P/c1-7-54(52,8-2)25-27-12-11-13-30(21-27)50-36(23-35(49-50)41(4,5)6)46-40(51)45-33-16-17-34(32-15-10-9-14-31(32)33)53-37-18-19-42-39(47-37)44-29-20-26(3)38-28(22-29)24-43-48-38/h9-24H,7-8,25H2,1-6H3,(H,43,48)(H,42,44,47)(H2,45,46,51)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354294 (1-(3-(tert-Butyl)-1-(4-(diethylphosphoryl)phenyl)-...) Show SMILES CCP(=O)(CC)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C38H40N7O3P/c1-6-49(47,7-2)28-19-17-27(18-20-28)45-34(25-33(44-45)38(3,4)5)42-37(46)41-31-21-22-32(30-16-12-11-15-29(30)31)48-35-23-24-39-36(43-35)40-26-13-9-8-10-14-26/h8-25H,6-7H2,1-5H3,(H,39,40,43)(H2,41,42,46)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354309 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354310 (3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354330 (3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(F)(F)F)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C45H49F3N9O5P/c1-44(2,3)38-27-39(57(55-38)33-10-8-9-29(23-33)28-63(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-32-25-30(24-31(26-32)45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354276 (1-(1-(4-(Dimethylphosphoryl)phenyl)-3-isopropyl-1H...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O Show InChI InChI=1S/C35H34N7O3P/c1-23(2)30-22-32(42(41-30)25-14-16-26(17-15-25)46(3,4)44)39-35(43)38-29-18-19-31(28-13-9-8-12-27(28)29)45-33-20-21-36-34(40-33)37-24-10-6-5-7-11-24/h5-23H,1-4H3,(H,36,37,40)(H2,38,39,43)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354311 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1 Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354333 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C44H48F3N8O5P/c1-43(2,3)38-27-39(55(53-38)32-10-8-9-29(23-32)28-61(4,5)57)51-42(56)50-36-13-14-37(35-12-7-6-11-34(35)36)60-40-15-16-48-41(52-40)49-31-24-30(44(45,46)47)25-33(26-31)59-22-19-54-17-20-58-21-18-54/h6-16,23-27H,17-22,28H2,1-5H3,(H,48,49,52)(H2,50,51,56)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354273 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 alpha (Homo sapiens (Human))	BDBM354275 (N-(4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylphosphor...) Show SMILES COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)ccn1 Show InChI InChI=1S/C34H37N6O5P/c1-34(2,3)29-20-31(40(39-29)22-11-13-24(14-12-22)46(5,6)43)38-33(42)36-27-15-16-28(26-10-8-7-9-25(26)27)45-23-17-18-35-30(19-23)37-32(41)21-44-4/h7-20H,21H2,1-6H3,(H,35,37,41)(H2,36,38,42)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354331 (3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC(F)(F)F)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C45H49F3N9O6P/c1-44(2,3)38-27-39(57(55-38)32-10-8-9-29(23-32)28-64(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-31-24-30(25-33(26-31)63-45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354324 (1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...) Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354329 (1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354317 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C44H52N7O8P/c1-30(2)39-28-41(51(50-39)33-11-9-10-31(24-33)29-60(5,6)53)48-44(52)47-38-14-15-40(37-13-8-7-12-36(37)38)59-42-16-17-45-43(49-42)46-32-25-34(55-4)27-35(26-32)58-23-22-57-21-20-56-19-18-54-3/h7-17,24-28,30H,18-23,29H2,1-6H3,(H,45,46,49)(H2,47,48,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354333 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C44H48F3N8O5P/c1-43(2,3)38-27-39(55(53-38)32-10-8-9-29(23-32)28-61(4,5)57)51-42(56)50-36-13-14-37(35-12-7-6-11-34(35)36)60-40-15-16-48-41(52-40)49-31-24-30(44(45,46)47)25-33(26-31)59-22-19-54-17-20-58-21-18-54/h6-16,23-27H,17-22,28H2,1-5H3,(H,48,49,52)(H2,50,51,56)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354322 (3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...) Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C45H51N8O6P/c1-30(2)40-28-43(53(51-40)34-10-8-9-31(23-34)29-60(4,5)56)50-45(55)49-39-13-14-41(38-12-7-6-11-37(38)39)59-35-15-16-46-42(27-35)48-33-24-32(25-36(26-33)57-3)44(54)47-17-18-52-19-21-58-22-20-52/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,46,48)(H,47,54)(H2,49,50,55)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354302 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES CN(CCCO)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1 Show InChI InChI=1S/C34H40N7O4P/c1-34(2,3)29-22-30(41(39-29)23-12-14-24(15-13-23)46(5,6)44)37-33(43)36-27-16-17-28(26-11-8-7-10-25(26)27)45-31-18-19-35-32(38-31)40(4)20-9-21-42/h7-8,10-19,22,42H,9,20-21H2,1-6H3,(H2,36,37,43)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354273 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354295 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-23-33(44(43-32)27-15-11-12-25(22-27)24-48(4,5)46)41-36(45)40-30-18-19-31(29-17-10-9-16-28(29)30)47-34-20-21-38-35(42-34)39-26-13-7-6-8-14-26/h6-23H,24H2,1-5H3,(H,38,39,42)(H2,40,41,45)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354293 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354314 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C37H37N6O3P/c1-25(2)33-23-36(43(42-33)28-14-10-11-26(21-28)24-47(3,4)45)41-37(44)40-32-17-18-34(31-16-9-8-15-30(31)32)46-29-19-20-38-35(22-29)39-27-12-6-5-7-13-27/h5-23,25H,24H2,1-4H3,(H,38,39)(H2,40,41,44)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	47	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM354313 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C38H39N6O3P/c1-38(2,3)34-24-36(44(43-34)28-15-11-12-26(22-28)25-48(4,5)46)42-37(45)41-32-18-19-33(31-17-10-9-16-30(31)32)47-29-20-21-39-35(23-29)40-27-13-7-6-8-14-27/h6-24H,25H2,1-5H3,(H,39,40)(H2,41,42,45)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	56	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354287 (1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...) Show SMILES CN(c1ccccc1)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1 Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-24-33(44(42-32)26-16-18-27(19-17-26)48(5,6)46)40-36(45)39-30-20-21-31(29-15-11-10-14-28(29)30)47-34-22-23-38-35(41-34)43(4)25-12-8-7-9-13-25/h7-24H,1-6H3,(H2,39,40,45)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	56	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354323 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(OCCN2CCOCC2)c1 Show InChI InChI=1S/C44H50N7O6P/c1-30(2)40-28-43(51(49-40)33-10-8-9-31(23-33)29-58(4,5)53)48-44(52)47-39-13-14-41(38-12-7-6-11-37(38)39)57-34-15-16-45-42(27-34)46-32-24-35(54-3)26-36(25-32)56-22-19-50-17-20-55-21-18-50/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,45,46)(H2,47,48,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	58	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354304 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12 Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	60	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM354314 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C37H37N6O3P/c1-25(2)33-23-36(43(42-33)28-14-10-11-26(21-28)24-47(3,4)45)41-37(44)40-32-17-18-34(31-16-9-8-15-30(31)32)46-29-19-20-38-35(22-29)39-27-12-6-5-7-13-27/h5-23,25H,24H2,1-4H3,(H,38,39)(H2,40,41,44)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	63	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354294 (1-(3-(tert-Butyl)-1-(4-(diethylphosphoryl)phenyl)-...) Show SMILES CCP(=O)(CC)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C38H40N7O3P/c1-6-49(47,7-2)28-19-17-27(18-20-28)45-34(25-33(44-45)38(3,4)5)42-37(46)41-31-21-22-32(30-16-12-11-15-29(30)31)48-35-23-24-39-36(43-35)40-26-13-9-8-10-14-26/h8-25H,6-7H2,1-5H3,(H,39,40,43)(H2,41,42,46)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	67	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 alpha (Homo sapiens (Human))	BDBM354292 (1-(4-((2-((3-Aminobenzo[d]isoxazol-5-yl)amino)pyri...) Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5onc(N)c5c4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O Show InChI InChI=1S/C37H36N9O4P/c1-37(2,3)31-21-32(46(44-31)23-11-13-24(14-12-23)51(4,5)48)42-36(47)41-28-15-17-29(26-9-7-6-8-25(26)28)49-33-18-19-39-35(43-33)40-22-10-16-30-27(20-22)34(38)45-50-30/h6-21H,1-5H3,(H2,38,45)(H,39,40,43)(H2,41,42,47)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	68	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354309 (1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...) Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1 Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	70	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM354332 (1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...) Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1 Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	71	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9796742 (2017) BindingDB Entry DOI: 10.7270/Q2KW5J5M
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 135 total )  |  Next  |  Last  >>

Jump to: